Avonex (Biogen Inc)
Avonex (Biogen Inc) Brand names, Avonex (Biogen Inc) Analogs
Avonex (Biogen Inc) Brand Names Mixture
- No information avaliable
Avonex (Biogen Inc) Chemical_Formula
C908H1408N246O252S7
Avonex (Biogen Inc) RX_link
http://www.rxlist.com/cgi/generic3/rebif.htm
Avonex (Biogen Inc) fda sheet
Avonex (Biogen Inc) msds (material safety sheet)
Avonex (Biogen Inc) Synthesis Reference
No information avaliable
Avonex (Biogen Inc) Molecular Weight
20027.0
Avonex (Biogen Inc) Melting Point
No information avaliable
Avonex (Biogen Inc) H2O Solubility
No information avaliable
Avonex (Biogen Inc) State
Liquid
Avonex (Biogen Inc) LogP
-0.427
Avonex (Biogen Inc) Dosage Forms
Solution (Subcutaneous Injection); Solution (Intra- or Peri-lesional Injection)
Avonex (Biogen Inc) Indication
For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum
Avonex (Biogen Inc) Pharmacology
Interferon beta upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Type I interferons also induce the synthesis of several key antiviral mediators including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin and neopterin.
Avonex (Biogen Inc) Absorption
No information avaliable
Avonex (Biogen Inc) side effects and Toxicity
No information avaliable
Avonex (Biogen Inc) Patient Information
No information avaliable
Avonex (Biogen Inc) Organisms Affected
No information avaliable
